Key result
Human genomic research has identified numerous genetic variations implicated in cardiovascular diseases, though successful application to personalized medicine requires further evaluation.
Despite significant progress in identifying genetic variants associated with cardiovascular diseases, the translation of genomic data into personalized clinical medicine remains challenging and requires further research.
Answers are grounded in this paper and cite their sources.
Genomic variants should not yet guide cardiovascular therapy; leaves open translation to personalized medicine.
For the past 10 years in the post-genomic era, emerging technologies in human genomic research have provided us with a plethora of genetic variations implicated in the pathogenesis of cardiovascular diseases. Discovering the key target genes in genomic research has contributed to biomedical research on the mechanical pathways of the diseases. In an era with dramatic development of brand new strategies, the conventional evaluation of family aggregation, environmental exposure and clinical phenotype remains of great importance to promote genomic research. Notwithstanding the promising progress in genomic research, we still have an enormous number of issues to overcome before approaching the ultimate goal of human genomics: the successful application of genomic data to personalized medicine.
No takes yet. Share an insight, caveat, or question.
Hiroyuki Morita (2013) conducted a review in Cardiovascular diseases. Human genomics was evaluated. Human genomic research has identified numerous genetic variations implicated in cardiovascular diseases, though successful application to personalized medicine requires further evaluation.
Synapse has enriched 10 related papers. Consider them for comparative context: